The present study found evidence supporting a potential causal relationship between the reduction in PD risk and higher serum TAG (51:4) levels and clarified the possible role of circulating immune cells (including IgD-CD38-B cell lymphocytes and resting CD4 regulatory T cell %CD4 + T cells), but not circulating inflammatory proteins. The gene discussed is CD38; the disease is Parkinson disease.